Locksley R M, Crowe S, Sadick M D, Heinzel F P, Gardner K D, McGrath M S, Mills J
Department of Medicine, University of California San Francisco Medical Center 94143.
J Clin Invest. 1988 Dec;82(6):2097-105. doi: 10.1172/JCI113831.
Infection of monocyte-macrophages with human immunodeficiency virus may be central to the pathogenesis of the acquired immunodeficiency syndrome. The ability of infected macrophages to prime T cells through IL-1 production was investigated in vitro. Purified human monocytes maintained in suspension culture were infected with strain HIV-DV. Intracellular expression of virus p24 antigen increased from undetectable levels immediately after infection to 13-59% of cells by 10-14 d; infected macrophages remained viable for up to 60 d. Supernatants collected between 14 and 20 d after infection were examined in the murine thymocyte co-mitogenesis assay and demonstrated to contain a potent IL-1 inhibitor, designated contra-IL-1. Contra-IL-1 activity was present in all supernatants examined after 4 d of infection, and peaked coincident with peak p24 antigen expression. Inhibitory activity was not present in uninfected cells. Contra-IL-1 activity eluted after gel filtration with an approximate molecular weight of 9 kD. Inhibitory activity was removed by exposure to heat or acid pH, or by incubation with chymotrypsin or staphylococcal V8 protease. Contra-IL-1 did not inhibit IL-2- or IL-4-dependent proliferation of murine T cell lines. Despite its ability to inhibit IL-1 activity, contra-IL-1 did not interfere with the binding of recombinant IL-1 beta to a fibroblast cell line. Contra-IL-1 inhibited the proliferation of normal peripheral blood mononuclear cells to both concanavalin A and tetanus toxoid; inhibition could be attenuated by the addition of exogenous IL-1. Messenger RNA extracted from infected macrophages was examined by Northern analysis for the presence of message to IL-1 beta. No message was apparent, suggesting that the presence of contra-IL-1 was not obscuring the concomitant release of IL-1. Infected macrophages stimulated with endotoxin generated readily detectable message for IL-1 beta. Spleen macrophages purified from two patients with AIDS complicated by immune thrombocytopenia spontaneously expressed p24 antigen in vitro and released contra-IL-1 activity into the media. Contra-IL-1 may contribute to the immune dysfunction of AIDS.
人类免疫缺陷病毒感染单核细胞 - 巨噬细胞可能是获得性免疫缺陷综合征发病机制的核心。在体外研究了受感染巨噬细胞通过产生白细胞介素 - 1(IL - 1)激活T细胞的能力。将悬浮培养的纯化人单核细胞用HIV - DV株感染。病毒p24抗原的细胞内表达从感染后即刻的不可检测水平增加到10 - 14天时细胞的13% - 59%;受感染的巨噬细胞存活长达60天。在感染后14至20天收集的上清液在小鼠胸腺细胞共刺激增殖试验中进行检测,结果显示含有一种有效的IL - 1抑制剂,命名为抗IL - 1。在感染4天后检测的所有上清液中均存在抗IL - 1活性,且其峰值与p24抗原表达峰值同时出现。未感染细胞中不存在抑制活性。抗IL - 1活性经凝胶过滤后洗脱,其近似分子量为9kD。通过加热、酸性pH处理或与胰凝乳蛋白酶或葡萄球菌V8蛋白酶孵育可去除抑制活性。抗IL - 1不抑制小鼠T细胞系依赖IL - 2或IL - 4的增殖。尽管抗IL - 1具有抑制IL - 1活性的能力,但它并不干扰重组IL - 1β与成纤维细胞系的结合。抗IL - 1抑制正常外周血单个核细胞对刀豆球蛋白A和破伤风类毒素的增殖;加入外源性IL - 1可减弱这种抑制作用。通过Northern分析检测从受感染巨噬细胞提取的信使核糖核酸(mRNA)中是否存在IL - 1β的信息。未发现明显信息,这表明抗IL - 1的存在并未掩盖IL - 1的同时释放。用内毒素刺激受感染的巨噬细胞可产生易于检测到的IL - 1β信息。从两名合并免疫性血小板减少症的艾滋病患者纯化的脾巨噬细胞在体外自发表达p24抗原,并将抗IL - 1活性释放到培养基中。抗IL - 1可能导致艾滋病的免疫功能障碍。